We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$841M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$752M
3
AAPL icon
Apple
AAPL
+$720M
4
TSLA icon
Tesla
TSLA
+$713M
5
NXPI icon
NXP Semiconductors
NXPI
+$648M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTEK
2176
DELISTED
Ultratech Inc.
UTEK
$293K ﹤0.01%
12,767
-33
-0.3% -$721
ANIK icon
2177
Anika Therapeutics
ANIK
$283M
$292K ﹤0.01%
5,440
– –
DIN icon
2178
Dine Brands
DIN
$440M
$292K ﹤0.01%
3,445
– –
TAST
2179
DELISTED
Carrols Restaurant Group, Inc.
TAST
$292K ﹤0.01%
24,500
+11,000
+81% +$144K
ZAGG
2180
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$292K ﹤0.01%
55,600
+31,300
+129% +$205K
FHI icon
2181
Federated Hermes
FHI
$4.74B
$291K ﹤0.01%
10,095
+400
+4% +$12.2K
RUSHA icon
2182
Rush Enterprises Class A
RUSHA
$9.62B
$291K ﹤0.01%
30,375
– –
TTEC icon
2183
TTEC Holdings
TTEC
$77.4M
$291K ﹤0.01%
10,730
– –
UI icon
2184
Ubiquiti
UI
$35.3B
$291K ﹤0.01%
7,540
+100
+1% +$3.71K
VRN
2185
DELISTED
Veren
VRN
$291K ﹤0.01%
18,500
-1,500
-8% -$24K
FARM
2186
DELISTED
Farmer Brothers
FARM
$290K ﹤0.01%
+9,040
New +$270K
VEA icon
2187
Vanguard FTSE Developed Markets ETF
VEA
$239B
$290K ﹤0.01%
8,200
– –
TAL
2188
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$290K ﹤0.01%
21,600
+6,500
+43% +$95.5K
AMCC
2189
DELISTED
Applied Micro Circuits Corporation New
AMCC
$288K ﹤0.01%
44,900
+14,500
+48% +$92.5K
GORO icon
2190
Goldgroup Mining Inc.
GORO
$211M
$286K ﹤0.01%
79,700
-9,000
-10% -$28.4K
THFF icon
2191
First Financial Corp
THFF
$975M
$285K ﹤0.01%
7,780
– –
MCBC
2192
DELISTED
Macatawa Bank Corp
MCBC
$283K ﹤0.01%
38,100
– –
NAV
2193
DELISTED
Navistar International
NAV
$283K ﹤0.01%
24,200
– –
ONIT
2194
Onity Group
ONIT
$330M
$282K ﹤0.01%
10,990
+3,047
+38% +$94.1K
PBIP
2195
DELISTED
Prudential Bancorp, Inc.
PBIP
$282K ﹤0.01%
+20,035
New +$291K
OSG
2196
Octave Specialty Group
OSG
$212M
$280K ﹤0.01%
17,000
– –
GPRO icon
2197
GoPro
GPRO
$117M
$280K ﹤0.01%
25,915
+120
+0.5% +$1.33K
HOV icon
2198
Hovnanian Enterprises
HOV
$799M
$280K ﹤0.01%
6,668
– –
MAGN
2199
Magnera Corp
MAGN
$433M
$280K ﹤0.01%
1,100
– –
TLRD
2200
DELISTED
Tailored Brands, Inc.
TLRD
$280K ﹤0.01%
22,150
+7,800
+54% +$115K
86 87
88
89 90

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.